Northwestern Mutual Wealth Management’s ANI Pharmaceuticals ANIP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.28K	Buy	100 +60	+150%	+$4.81K	﹤0.01%	3187
2026 Q1	$3.08K	Sell	40 -30	-43%	-$2.34K	﹤0.01%	3465
2025 Q4	$5.53K	Buy	70 +30	+75%	+$2.6K	﹤0.01%	3195
2025 Q3	$3.66K	Hold	40	–	–	﹤0.01%	3243
2025 Q2	$2.61K	Hold	40	–	–	﹤0.01%	3189
2025 Q1	$2.68K	Hold	40	–	–	﹤0.01%	3082
2024 Q4	$2.21K	Hold	40	–	–	﹤0.01%	3153
2024 Q3	$2.39K	Buy	+40	New	+$2.44K	﹤0.01%	3084
2024 Q1	–	Sell	-8,500	Closed	-$469K	–	3567
2023 Q4	$469K	Buy	8,500 +8,382	+7,103%	+$462K	﹤0.01%	1232
2023 Q3	$6.85K	Buy	+118	New	+$6.81K	﹤0.01%	2657
2022 Q3	–	Sell	-1	Closed	–	–	3099
2022 Q2	$0	Buy	+1	New	+$29	﹤0.01%	3159
2018 Q1	–	Sell	-33	Closed	-$2K	–	2182
2017 Q4	$2K	Buy	+33	New	+$2.05K	﹤0.01%	2062
2017 Q1	–	Sell	-113	Closed	-$7K	–	2005
2016 Q4	$7K	Hold	113	–	–	﹤0.01%	1722
2016 Q3	$7K	Buy	113 +51	+82%	+$3.19K	﹤0.01%	1598
2016 Q2	$3K	Hold	62	–	–	﹤0.01%	1728
2016 Q1	$2K	Buy	+62	New	+$2.1K	﹤0.01%	1862

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northwestern Mutual Wealth Management's ANIP Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its ANI Pharmaceuticals (ANIP) stake by 150% in Q2 2026, buying an estimated $4.81K and bringing the position to 100 shares worth $8.28K. The position accounts for ﹤0.01% of the portfolio, ranked #3187.

Northwestern Mutual Wealth Management first reported a position in ANIP in Q1 2016 and has held it in 16 quarters since. The position peaked at $469K in Q4 2023. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Northwestern Mutual Wealth Management held 100 shares of ANI Pharmaceuticals worth $8.28K as of Q2 2026.
Northwestern Mutual Wealth Management bought 60 ANI Pharmaceuticals shares in Q2 2026, an estimated $4.81K.
ANI Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3187 holding.
Northwestern Mutual Wealth Management first reported a position in ANI Pharmaceuticals in Q1 2016 and has held it in 16 quarters since.
Northwestern Mutual Wealth Management's ANI Pharmaceuticals position peaked at $469K in Q4 2023.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.